SLU-PP-332 5mg — Vial Spec, Reconstitution Math & COA

SLU-PP-332 5mg Lyophilized Powder Overview

A 5mg vial of SLU-PP-332 contains exactly 5.0 milligrams of high-purity, lyophilized solid synthesized for targeted laboratory evaluation. SLU-PP-332 is a novel small-molecule agonist designed to selectively activate the estrogen-related receptor alpha (ERRα), a key nuclear receptor responsible for regulating mitochondrial biogenesis, oxidative phosphorylation, and cellular energy homeostasis in muscle and metabolic tissues.

Principal investigators and laboratory managers typically order the 5mg vial configuration when establishing initial dose-response curves in rodent tissue assays, conducting short-term benchtop cell culture experiments, or verifying receptor binding kinetics before scaling up to larger study cohorts. PX1 Research supplies high-grade chemical reference standards and research compounds, ensuring every vial maintains absolute consistency across lot runs. Researchers looking to explore our full inventory of laboratory reagents can review our entire catalog of research peptides and compounds.

Molecular Mechanism & ERRα Receptor Activity

SLU-PP-332 functions as a potent, synthetic agonist of ERRα, a nuclear receptor that operates downstream of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). In skeletal muscle and cardiac tissue, ERRα expression governs transcription factors that direct fatty acid oxidation, mitochondrial electron transport chain gene expression, and energy substrate utilization.

Preclinical studies indicate that activation of ERRα by SLU-PP-332 upregulation promotes a shift toward oxidative muscle fiber phenotypes without requiring physical muscle contraction. In vitro data demonstrate that treated cell lines exhibit elevated oxygen consumption rates (OCR) and increased expression of genes involved in mitochondrial respiration. Researchers exploring metabolic and endurance pathways often access our metabolic research hub to evaluate technical documentation on nuclear receptor targets.

Reconstitution Mathematics for a 5mg Vial

Accurate reconstitution is critical for maintaining experimental rigor and reproducibility across assays. Because SLU-PP-332 is a hydrophobic small molecule, initial dissolution requires laboratory-grade dimethyl sulfoxide (DMSO) or ethanol prior to dilution in aqueous buffer systems such as phosphate-buffered saline (PBS), depending on the specific cell line or animal assay requirements. Below are the calculated final stock concentrations when dissolving a 5mg mass into standard laboratory diluent volumes:

1.0 mL Diluent: Adding 1.0 mL of solvent yields a final concentration of 5.0 mg/mL (5.0 µg/µL). This concentrated stock solution is ideal for high-yield micro-aliquoting, minimizing total liquid volume added to cell culture wells.

2.0 mL Diluent: Adding 2.0 mL of solvent yields a final concentration of 2.5 mg/mL (2.5 µg/µL). This intermediate stock concentration allows for precise pipette delivery across microplate assays requiring sub-milligram dosing parameters.

3.0 mL Diluent: Adding 3.0 mL of solvent yields a final concentration of 1.67 mg/mL (1.67 µg/µL). This lower density stock is suitable for larger volume working solutions where precise volumetric measurement is necessary.

For complex dilution schemes, multi-compound comparative studies, or adjusting target molarities, investigators are encouraged to utilize our interactive reconstitution calculator to eliminate manual volumetric errors.

Aliquoting Strategies & Freeze-Thaw Degradation Prevention

Repetitive freeze-thaw cycles significantly accelerate chemical degradation, peptide bond hydrolysis, and precipitation out of solution. Once a 5mg vial of SLU-PP-332 is fully reconstituted into a stock solution, the compound must be divided into single-use micro-centrifuge tubes based on projected assay requirements.

Working inside a sterile laminar flow hood, dispense stock solutions into pre-sterilized polypropylene micro-aliquots (e.g., 50 µL to 100 µL per tube). Immediately flash-freeze the aliquots using liquid nitrogen or a dry ice/ethanol bath before transferring them to long-term storage at -80°C. Individual aliquots should be thawed only once immediately prior to assay execution, discarding any unused portion to preserve analytical validity.

Comparative Analysis: Powder Vials vs. Alternative Formulations

Selecting the correct product physical state depends on the experimental model, dosing interface, and administration protocol. Lyophilized 5mg powder vials offer maximum flexibility for liquid preparation, custom solvent mixtures, and variable concentration scales required for precise in vitro assays and parenteral animal models.

For studies specifically requiring solid-state oral administration models or standardized unit-dose research protocols, alternative formats are available. Investigators evaluating oral delivery pathways in preclinical models can review our SLU-PP-332 250mcg research capsules as a reference standard. If your laboratory requires specific custom fill sizes, custom solution concentrations, or bulk mass orders, please consult our institutional wholesale supply program.

Comparative Benchmarking: SLU-PP-332 vs. Related Endurance Compounds

In metabolic and physical capacity research, SLU-PP-332 is frequently evaluated alongside other synthetic modulators targeting cellular energy expenditure and oxidative capacity. Understanding how SLU-PP-332 compares to established research molecules allows laboratories to construct robust target-validation protocols.

While SLU-PP-332 operates specifically as a direct ERRα agonist, compounds like GW501516 act as selective PPARδ agonists, driving cellular lipid oxidation through distinct nuclear pathways. Similarly, SR9009 targets Rev-ErbA to modulate circadian metabolic rhythms and mitochondrial density, whereas mitochondrial peptides such as MOTS-c signal through AMP-activated protein kinase (AMPK) pathways. Comparing these distinct modes of action allows researchers to cross-examine mitochondrial biogenesis from multiple nuclear and organelle signaling angles.

Quality Assurance: HPLC, MS, and COA Verification for 5mg Lots

PX1 Research enforces stringent quality control measures on every production batch to guarantee chemical identity, purity, and uniformity. Each 5mg vial of SLU-PP-332 undergoes independent, third-party laboratory verification within ISO 17025 accredited facilities prior to distribution.

Purity is verified using High-Performance Liquid Chromatography (HPLC), confirming a target purity threshold of ≥98.0%. Mass Spectrometry (MS) is conducted concurrently to confirm correct molecular mass and structural identity, ruling out synthetic impurities or residual unreacted reagents. Furthermore, bacterial endotoxin testing (LAL assay) is conducted on all lots to ensure compatibility with sensitive cell cultures. Investigators can access and download lot-matched reports directly through our certificate of analysis portal.

Storage, Handling, and Long-Term Stability Protocols

Proper storage conditions are required to maintain chemical stability and prevent compound degradation over time. Unreconstituted 5mg vials of lyophilized SLU-PP-332 should be stored in a dry, dark environment at -20°C for short-to-medium term storage (up to 12 months), or at -80°C for extended archival storage.

Vials should be protected from direct light exposure and allowed to acclimate to ambient room temperature inside a desiccator prior to opening or reconstitution. Desiccation during the warming phase prevents atmospheric moisture condensation on the lyophilized cake, which can alter dry mass measurements and initiate premature degradation reactions.

Determining the Right Vial Mass for Your Experimental Design

Selecting the ideal vial mass depends on study scale, subject count, and timeline. The 5mg vial size is specifically engineered to minimize waste during preliminary validation, pilot studies, and short-term cell culture experiments where large stock volumes are unnecessary and subject to degradation over time.

For multi-week animal study cohorts, continuous cell line passages, or high-throughput screens requiring constant stock concentrations, larger total masses or multiple single-use 5mg vials should be utilized to maintain consistent batch preparation. Utilizing multiple fresh 5mg vials ensures that stock solutions remain pristine without suffering from extended liquid storage instability.